| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10912179 | Lung Cancer | 2005 | 6 Pages |
Abstract
The results from this prospective trial demonstrate the poor predictive value of current clinical staging techniques in early stage NSCLC. These findings will serve as a benchmark for comparison of future clinical imaging modalities and other tests evaluating early stage NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jonathan D'Cunha, James E. II, Debra L. Herzan, G. Alexander Patterson, Leslie J. Kohman, David H. Harpole, Kemp H. Kernstine, Jeffrey A. Kern, Mark R. Green, Michael A. Maddaus, Robert A. Kratzke,